Medicamen Biotech inks agreement with Vital Pharma Nordic

12 Aug 2022 Evaluate

Medicamen Biotech has entered into long term agreement with Vital Pharma Nordic, a Denmark based company, for CDMO (contract development and manufacturing company) for multiple products. Vital Pharma Nordic (VPN) is led by highly experienced specialists and engaged in licensing, development, distribution and sales of specialty Gx pharmaceuticals. VPN operate in the Nordic region now expanding internationally.

Medicamen Biotech is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.

Medicamen Biotech Share Price

301.15 -0.90 (-0.30%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×